Treatment of aneurysmal subarachnoid haemorrhage in elderly patients

Journal of Clinical Pharmacy and Therapeutics

Volumn 26, Issue 4, 2001, Pages 247-256

  Sarkar, P K ^a,c   D'Souza, C ^b   Ballantyne, S ^b  

^a SELLY OAK HOSPITAL   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Elderly patients; Subarachnoid haemorrhage; Treatment

Indexed keywords

AMINOCAPROIC ACID; ANTICONVULSIVE AGENT; ANTIFIBRINOLYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; FASUDIL; METHYLPREDNISOLONE; NICARDIPINE; NIMODIPINE; PHENYTOIN; TIRILAZAD; TRANEXAMIC ACID;

AGE; ANEURYSM RUPTURE; ANEURYSM SURGERY; BRAIN HEMATOMA; BRAIN INFARCTION; CLINICAL TRIAL; CRANIOTOMY; DIAGNOSTIC VALUE; EPILEPSY; HUMAN; HYDROCEPHALUS; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; SUBARACHNOID HEMORRHAGE; SURVIVAL RATE; TREATMENT OUTCOME; VASOSPASM;

AGE FACTORS; AGED; CRANIOTOMY; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; INTRACRANIAL ANEURYSM; PATIENT SELECTION; PROGNOSIS; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035722228     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2001.00349.x     Document Type: Review

References (78)

1. Intracranial aneurysms
2. Subarachnoid haemorrhage. Epidemiology, diagnosis, management, and outcome
3. The unchanging pattern of subarachnoid haemorrhage in a community
4. Subarachnoid and intracerebral haemorrhage: Natural history, prognosis, and precursive factors in the Framingham study
5. Management of elderly patients with aneurysmal subarachnoid haemorrhage
6. Perioperative and intensive care unit care of patients with aneurysmal subarachnoid haemorrhage
7. Assessment of the natural history of anterior communicating aneurysms
8. Prognostic factors in the untreated course of posterior communicating aneurysms
9. Intracranial aneurysms and subarachnoid haemorrhage: Report on a randomized treatment study, IV-B: Regulated bed rest: Statistical evaluation
10. The long term prognosis in untreated cerebral aneurysms, I: The incidence of late haemorrhage in cerebral aneurysms: A 10 year evaluation of 364 patients
11. The risk of subarachnoid and intracerebral haemorrhages in blacks as compared with whites
12. Epidemiology of subarachnoid haemorrhage
13. Risk factors for subarachnoid haemorrhage
14. Cigarette smoking, alcohol use, and subarachnoid haemorrhage
15. Cigarette smoking, hypertension and the risk of subarachnoid haemorrhage: A population-based case-control study
16. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid haemorrhage
17. Smoking and subarachnoid haemorrhage: A case-control study
18. Risk factors for subarachnoid haemorrhage in a longitudinal population study
19. Cigarette smoking and subarachnoid haemorrhage: A population-based case-control study
20. Alcohol use and subsequent cerebrovascular disease hospitalisations
21. Alcohol consumption: A risk factor for haemorrhagic and non-haemorrhagic stroke
22. Cocaine-induced aneurysmal rupture: An emergent factor in the natural history of intracranial aneurysms?
23. Prevalence of diabetes mellitus among patients with subarachnoid haemorrhage
24. Unruptured intracranial aneurysms: An assessment of the annual risk of rupture based on epidemiological and clinical data
25. The natural histroy of aneurysms and arterio-venous malformations
26. The size of intracranial saccular aneurysms: An autopsy study
27. The significance of unruptured intracranial saccular aneurysms
28. The relationship of ventricular drainage to aneurysmal rebleeding
29. Rebleeding from ruptured intracranial aneurysms
30. The effects of treating hypertension following aneurysmal subarachnoid haemorrhage
31. Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving anti-fibrinolytic therapy: Report of the Cooperative Aneurysm study
32. Terson's syndrome in subarachnoid haemorrhage and severe brain injury accompanied by acutely raised intracranial pressure
33. Pathogenesis and treatment of Terson-syndrome
34. Le syndrome du corps vitre et de l'hemorrhagic intracranienne spontane
35. Delay in referral of patients with ruptured aneurysms to neurosurgical attention
36. Warning leaks and subarachnoid haemorrhage
37. The minor leak preceding subarachnoid haemorrhage
38. The International Coopertive study on the Timing of Aneurysm Surgery, I: Overall management results
39. MR imaging is highly sensitive for acute subarachnoid haemorrhage ... Not!
40. Guidelines for the Management of Aneurysmal Subarachnoid Haemorrhage: A statement for health-care professionals, from a Special Writing Group of the Stroke Council, American Heart Association
41. Surgical risk as related to the time of intervention in the repair of intracranial aneurysms
42. Report on the cooperative study of intracranial aneurysms and subarachnoid haemorrhage, Section V, Part II: Natural history of subarachnoid haemorrhage, intracranial aneurysms and arteriovenous malformations
43. Early intervention with nimodipine in subarachnoid haemorrhage
44. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial
45. Prevention of vasospasm in subarachnoid haemorrhage: A controlled study with nimodipine
46. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid haemorrhage: A report of the cooperative aneurysm study
47. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid haemorrhage: Result of a prospective placebo-controlled double-blind trial
48. Calcium antagonists in patients with aneurysmal subarachnoid haemorrhage. A systematic review
49. Calcium antagonists for aneurysmal subarachnoid haemorrhage
50. Effects of intracisternal methylprednisolone on lipid peroxidation in experimental subarachnoid haemorrhage
51. Double-blind, randomized, vehicle-controlled study of high dose tirilazad mesylate in women with aneurysmal subarachnoid haemorrhage. Part II. A cooperative study in North America
52. A randomized, double blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid haemorrhage. A cooperative study in North America
53. Hypertension, age and residence in the survival with subarachnoid haemorrhage
54. Surgical experience of aged patients with ruptured intracranial aneurysms
55. The natural history of intracranial aneurysms: Rebleeding rates during acute and long term period and implication for surgical management
56. Subarachnoid haemorrhage above the age of 59: Are intracranial investigations justified?
57. Analysis of results of treatment of ruptured intracranial aneurysm
58. Aneurysm surgery in patients over the age of 80 years
59. Improved outcome following rupture of anterior circulation aneurysms: A retrospective 10 year review of 224 good grade patients
60. Predicting outcome in poor grade subarachnoid haemorrhage: A retrospective review of 159 aggressively managed patients
61. Clinical course of spontaneous subarachnoid haemorrhage: A population-based study in King County, Washington
62. The international cooperative study on the timing of aneurysm surgery. Part II: Surgical results
63. Craniotomy for intracranial aneurysm and subarachnoid haemorrhage. Is course, cost, or outcome affected by age?
64. Subarachnoid haemorrhage and cerebral aneurysms in the elderly
65. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid haemorrhage
66. Progress in the management of patients with aneurysmal subarachnoid haemorrhage: A single hospital review for 20 years. Part II: Aged patients
67. Endovascular treatment of intracranial aneurysms: A minimally invasive approach with advantages for elderly patients
68. Endovascular treatment of posterior circulation aneurysms by electrothrombosis using electrically detachable coils
69. Selective endovascular treatment of 71 intracranial aneurysms with platinum coils
70. Intracranial aneurysm surgery in the 8th and 9th decades of life: Impact on population-based management outcome
71. Age as a prognostic factor after intracranial aneurysm rupture
72. Mortality rates, hospital length of stay, and the cost of treating SAH in older patients: Institutional and geographical differences
73. Assessment of outcome after severe brain damage